Five Year Efficacy and Safety Analysis of the Adenoma Prevention with Celecoxib (APC) Trial

The Adenoma Prevention with Celecoxib (APC) Trial examined the efficacy and safety of the Cox-2 inhibitor, celecoxib, for sporadic colorectal adenoma prevention in patients at high risk for colorectal cancer (CRC). The trial randomized 2035 subjects to receive either placebo, celecoxib 200mg twice d...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Bertagnolli, Monica M., Eagle, Craig J., Zauber, Ann G., Redston, Mark, Breazna, Aurora, Kim, KyungMann, Tang, Jie, Rosenstein, Rebecca B., Umar, Asad, Bagheri, Donya, Collins, Neal T., Burn, John, Chung, Daniel C., Dewar, Thomas, Foley, T. Raymond, Hoffman, Neville, Macrae, Finlay, Pruitt, Ronald E., Saltzman, John R., Salzberg, Bruce, Sylwestrowicz, Thomas, Hawk, Ernest T.
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976587/
https://ncbi.nlm.nih.gov/pubmed/19336730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0206
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki